1
|
Di Franco C, Nocera I, Melanie P, Briganti A. Evaluation of the Quality of Recovery from General Anesthesia in Dogs with Two Different Low Doses of Dexmedetomidine. Animals (Basel) 2024; 14:1383. [PMID: 38731387 DOI: 10.3390/ani14091383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2024] [Revised: 05/01/2024] [Accepted: 05/02/2024] [Indexed: 05/13/2024] Open
Abstract
The purpose of this study was to evaluate the quality of recovery from general anesthesia with the administration of two low doses of dexmedetomidine in canine patients. For this blind randomized clinical trial study, 30 dogs undergoing general anesthesia for diagnostic procedures or elective surgery (ovariectomy/castration) were included. The patients were randomly divided into three groups, and at the end of anesthesia, they received a bolus of dexmedetomidine at 1 mcg/kg IV (D1), or a bolus of dexmedetomidine at 0.5 mcg/kg (D0.5), or a bolus of NaCl, in a total of 0.5 mL of solution for all three groups. After administration of the bolus, the anesthetist monitored the patients every 5 min by measuring heart rate, systolic and mean blood pressure, respiratory rate, and oxygen saturation. The quality of recovery was also assessed using 4 different scales. The extubation time, time of headlift, and standing position were also recorded. Both groups receiving dexmedetomidine had better awakening and a lower incidence of delirium when compared to saline administration. The heart rate was lower, while the systolic pressure was higher in the two groups D1 and D0.5 compared to the NaCl with a low presence of atrioventricular blocks. The extubation time resulted significantly higher in the D1 (17 ± 6 min) compared to the D0.5 (10 ± 4 min) and NaCl (8 ± 3 min) (p < 0.0001); the headlift time D1 (25 ± 10 min) resulted significantly longer than the NaCl group (11 ± 5 min) (p = 0.0023) but not than the D0.5 (18 ± 9 min). No significant differences were found among the three groups for standing positioning (D1 50 ± 18 min, D0.5 39 ± 22 min, NaCl 28 ± 17 min). The preventive administration of a bolus of dexmedetomidine at a dosage of 0.5 mcg/kg or 1 mcg/kg IV during the recovery phase improves the quality of recovery in patients undergoing general anesthesia.
Collapse
Affiliation(s)
- Chiara Di Franco
- Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy
| | - Irene Nocera
- Institute of Health Sciences, Sant'Anna School of Advanced Studies, 56127 Pisa, Italy
| | - Pierre Melanie
- Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy
| | - Angela Briganti
- Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy
| |
Collapse
|
2
|
Sorce G, Stabile A, Pellegrino F, Mazzone E, Mattei A, Afferi L, Serni S, Minervini A, Roumiguiè M, Malavaud B, Valerio M, Rakauskas A, Marra G, Gontero P, Porpiglia F, Guo H, Zhuang J, Gandaglia G, Montorsi F, Briganti A. The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology. World J Urol 2024; 42:248. [PMID: 38647689 DOI: 10.1007/s00345-024-04963-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2023] [Accepted: 03/25/2024] [Indexed: 04/25/2024] Open
Abstract
PURPOSE Although targeted biopsies (TBx) are associated with improved disease assessment, concerns have been raised regarding the risk of prostate cancer (PCa) overgrading due to more accurate biopsy core deployment in the index lesion. METHODS We identified 1672 patients treated with radical prostatectomy (RP) with a positive mpMRI and ISUP ≥ 2 PCa detected via systematic biopsy (SBx) plus TBx. We compared downgrading rates at RP (ISUP 4-5, 3, and 2 at biopsy, to a lower ISUP) for PCa detected via SBx only (group 1), via TBx only (group 2), and eventually for PCa detected with the same ISUP 2-5 at both SBx and TBx (group 3), using multivariable logistic regression models (MVA). RESULTS Overall, 12 vs 14 vs 6% (n = 176 vs 227 vs 96) downgrading rates were recorded in group 1 vs group 2 vs group 3, respectively (p < 0.001). At MVA, group 2 was more likely to be downgraded (OR 1.26, p = 0.04), as compared to group 1. Conversely, group 3 was less likely to be downgraded at RP (OR 0.42, p < 0.001). CONCLUSIONS Downgrading rates are highest when PCa is present in TBx only and, especially when the highest grade PCa is diagnosed by TBx cores only. Conversely, downgrading rates are lowest when PCa is identified with the same ISUP through both SBx and TBx. The presence of clinically significant disease at SBx + TBx may indicate a more reliable assessment of the disease at the time of biopsy potentially reducing the risk of downgrading at final pathology.
Collapse
Affiliation(s)
- G Sorce
- Unit of Urology, Division of Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy
| | - A Stabile
- Unit of Urology, Division of Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
- Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.
| | - F Pellegrino
- Unit of Urology, Division of Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy
| | - E Mazzone
- Unit of Urology, Division of Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy
| | - A Mattei
- Klinik Für Urologie, Luzerner Kantonsspital, Luzerner, Switzerland
| | - L Afferi
- Klinik Für Urologie, Luzerner Kantonsspital, Luzerner, Switzerland
| | - S Serni
- Department of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy
| | - A Minervini
- Department of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy
| | - M Roumiguiè
- Department of Urology and Renal Transplantation, Toulouse University Hospital, Toulouse, France
| | - B Malavaud
- Department of Urology and Renal Transplantation, Toulouse University Hospital, Toulouse, France
| | - M Valerio
- Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
| | - A Rakauskas
- Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
| | - G Marra
- Department of Urology, Città della Salute e della Scienza, University of Turin, Turin, Italy
| | - P Gontero
- Department of Urology, Città della Salute e della Scienza, University of Turin, Turin, Italy
| | - F Porpiglia
- Division of Urology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy
| | - H Guo
- Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China
| | - J Zhuang
- Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China
| | - G Gandaglia
- Unit of Urology, Division of Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy
| | - F Montorsi
- Unit of Urology, Division of Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy
| | - A Briganti
- Unit of Urology, Division of Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy
| |
Collapse
|
3
|
Vitale V, Bindi F, Briganti A, Bonelli F, Parietti C, Sgorbini M. Evaluation of bronchoalveolar lavage fluid from donkeys using four different cytological stains: A pilot study. J Equine Vet Sci 2024; 135:105035. [PMID: 38423373 DOI: 10.1016/j.jevs.2024.105035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Revised: 02/25/2024] [Accepted: 02/26/2024] [Indexed: 03/02/2024]
Abstract
Bronchoalveolar lavage fluid (BALF) cytology is used for the diagnosis of non-infectious lower airway inflammation in equids. Discrepancies have been reported in the differential cell count when different staining methods were used both in humans and horses. The objective of this study was to compare the results of BALF cytology in donkeys using four different staining methods: modified May-Grunwald Giemsa (mMGG), Diff-Quick (DQ), Toluidine blue (TB) and Perls Prussian blue (PPB). Nine healthy Amiata female donkeys were enrolled. The BAL procedure was performed as previously described and pairs of cytocentrifuged BALF slides were stained with each method. No differences between mMGG and DQ were found for macrophages, neutrophils, and eosinophils, while differences were found in mast cell count between DQ vs.TB, but not between mMGG vs. DQ or mMGG vs. TB. Finally, no differences were obtained in the differential count for hemosiderophages comparing mMGG, DQ and PPB. The mMGG appears to be an excellent stain for the identification of all possible cell types, including mast cells in the BALF of donkeys. DQ, if used alone, may lead to inappropriate identification of mast cells. These results are consistent with the literature on BALF staining methods in horses.
Collapse
Affiliation(s)
- V Vitale
- Universidad CEU-Cardenal Herrera, CEU Universities, 46115 Alfara del Patriarca, Valencia, Spain.
| | - F Bindi
- Department of Veterinary Sciences, University of Pisa, 56122 San Piero a Grado, Pisa, Italy
| | - A Briganti
- Department of Veterinary Sciences, University of Pisa, 56122 San Piero a Grado, Pisa, Italy
| | - F Bonelli
- Department of Veterinary Sciences, University of Pisa, 56122 San Piero a Grado, Pisa, Italy
| | - C Parietti
- Department of Veterinary Sciences, University of Pisa, 56122 San Piero a Grado, Pisa, Italy
| | - M Sgorbini
- Department of Veterinary Sciences, University of Pisa, 56122 San Piero a Grado, Pisa, Italy
| |
Collapse
|
4
|
Degani M, Briganti A, Dupont J, Tutunaru A, Picavet PP, Bolen G, Sandersen C. Perioperative analgesic efficacy of lumbar erector spinae plane block in dogs undergoing hemilaminectomy: a randomized blinded clinical trial. Vet Anaesth Analg 2024; 51:181-189. [PMID: 38331675 DOI: 10.1016/j.vaa.2023.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2023] [Revised: 10/29/2023] [Accepted: 12/04/2023] [Indexed: 02/10/2024]
Abstract
OBJECTIVE To evaluate the perioperative analgesic effect of the unilateral lumbar erector spinae plane block (ESPBL) in dogs undergoing hemilaminectomy. STUDY DESIGN Randomized, blinded clinical study. ANIMALS A total of 30 client-owned dogs undergoing thoracolumbar or lumbar hemilaminectomy for intervertebral disc extrusion (IVDE). METHODS Dogs were randomly assigned to receive a unilateral ESPBL, performed either with 0.4 mL kg-1 ropivacaine 0.5% [group ROPI (n = 15)] or with saline solution [CNT group (n = 15)]. Dogs were premedicated intravenously (IV) with acepromazine 5 μg kg-1 and methadone 0.2 mg kg-1, general anaesthesia was induced by administering IV midazolam 0.2 mg kg-1 and propofol to effect and maintained with isoflurane. Fentanyl was administered as rescue analgesia. Bradycardia [heart rate (HR) < 60 beats minute-1] with hypotension was treated with atropine IV. The Short-Form of the Glasgow Composite Pain Scale was used pre- and postoperatively at 1, 2, 4, 8, 12, 16, 20 and 24 hours after extubation, and methadone 0.2 mg kg-1 was administered IV when pain score was ≥ 5/20. HR and end-tidal concentration of isoflurane (Fe'Iso) were compared between groups with anova combined with a Dunnet's post hoc test. Time to the first rescue methadone and total dose of fentanyl (FENtot, μg kg-1 hour-1) and methadone (METtot, mg kg-1) in the first 24 postoperative hours were compared using unpaired Student's t test. Postoperative pain scores were compared with the Mann-Whitney test and atropine administration with a Fisher's exact test; p < 0.05. RESULTS HR, Fe'Iso, FENtot, METtot and atropine administration were significantly lower in group ROPI compared to CNT. Postoperative analgesic effect was significantly longer, and pain scores were significantly lower in group ROPI for all time points. CONCLUSIONS AND CLINICAL RELEVANCE Unilateral ESPBL with ropivacaine reduced perioperative opioid consumption and the occurrence of bradycardia in dogs undergoing hemilaminectomy.
Collapse
Affiliation(s)
- Massimiliano Degani
- Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium.
| | - Angela Briganti
- Department of Veterinary Sciences, Veterinary Teaching Hospital "Mario Modenato", University of Pisa, Pisa, Italy
| | - Julien Dupont
- Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium
| | - Alexandru Tutunaru
- Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium
| | - Pierre P Picavet
- Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium
| | - Géraldine Bolen
- Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium
| | - Charlotte Sandersen
- Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium
| |
Collapse
|
5
|
Vicenti C, Otero PE, Briganti A, Rondelli V, Stabile M, Piemontese C, Crovace A, Lacitignola L, Staffieri F. Respiratory Effects of Continuous Positive Airway Pressure Administered during Recovery from General Anesthesia in Brachycephalic Dogs. Vet Sci 2024; 11:75. [PMID: 38393093 PMCID: PMC10893332 DOI: 10.3390/vetsci11020075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2023] [Revised: 01/20/2024] [Accepted: 02/01/2024] [Indexed: 02/25/2024] Open
Abstract
This study aimed to evaluate the benefits of applying 5 cmH2O of CPAP using a pediatric helmet during the recovery phase from general anesthesia in brachycephalic dogs. Brachycephalic dogs undergoing various surgical procedures were included in this study, and a total of 64 subjects were randomly assigned to receive either standard oxygen supplementation (NO-CPAP group) or oxygen supplementation combined with CPAP (CPAP group). This study evaluated arterial blood pH, blood gas partial pressures of O2 and CO2, arterial blood O2 saturation, and related parameters during recovery. The dogs were monitored, and helmet tolerance was assessed using predefined criteria. Of the initially assessed 69 dogs, 64 were enrolled: 32 in the CPAP group and 32 in the NO-CPAP group. Fifteen dogs in the NO-CPAP group were excluded based on predetermined criteria. The CPAP group showed significant improvements in PaO2, PaO2/FiO2, P(A-a)O2, F-Shunt, and respiratory rate compared with the NO-CPAP group (p < 0.001). The incidence of reintubation and helmet intolerance was higher in the NO-CPAP group (18% and 15.6%, respectively) than in the CPAP group (0%). This study highlights the potential benefits of incorporating CPAP, delivered through a pediatric helmet, in the perioperative management of brachycephalic dogs.
Collapse
Affiliation(s)
- Caterina Vicenti
- Section of Veterinary Clinics and Animal Production, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari, 70010 Valenzano, Italy
| | - Pablo E Otero
- Section of Veterinary Clinics and Animal Production, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari, 70010 Valenzano, Italy
- Department of Anesthesiology and Pain Management, Facultad de Ciencias Veterinarias, Universidad de Buenos Aires, Buenos Aires C1427CWN, Argentina
| | - Angela Briganti
- Department of Veterinary Sciences, Veterinary Teaching Hospital "Mario Modenato", University of Pisa, 56122 Pisa, Italy
| | | | - Marzia Stabile
- Section of Veterinary Clinics and Animal Production, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari, 70010 Valenzano, Italy
| | - Claudia Piemontese
- Section of Veterinary Clinics and Animal Production, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari, 70010 Valenzano, Italy
| | - Antonio Crovace
- Section of Veterinary Clinics and Animal Production, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari, 70010 Valenzano, Italy
| | - Luca Lacitignola
- Section of Veterinary Clinics and Animal Production, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari, 70010 Valenzano, Italy
| | - Francesco Staffieri
- Section of Veterinary Clinics and Animal Production, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari, 70010 Valenzano, Italy
| |
Collapse
|
6
|
De Marchi L, Vernaccini M, Meucci V, Briganti A, Lippi I, Marchetti V, Intorre L. Six-Year Prescription Pattern of Antimicrobial Use in Cats at the Veterinary Teaching Hospital of the University of Pisa. Animals (Basel) 2024; 14:521. [PMID: 38338164 PMCID: PMC10854698 DOI: 10.3390/ani14030521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2023] [Revised: 01/19/2024] [Accepted: 02/01/2024] [Indexed: 02/12/2024] Open
Abstract
The use of antimicrobials has greatly contributed to improving animal health. However, their inappropriate use reduces their effectiveness in treating bacterial infections and contributes to the selection of resistance. This study aimed to retrospectively evaluate the six-year pattern (2017-2022) of antimicrobial use in cats visiting the Veterinary Teaching Hospital (VTH) of the University of Pisa (Italy). The total number of prescribed antimicrobials, the number of animals for which an antimicrobial was prescribed, and the total number of antimicrobial prescriptions showed a significant time trend decrease during the study period, except for the fixed-dose combinations. The most frequently prescribed antimicrobials were amoxicillin-clavulanic acid (Synulox) (39.1%) followed by enrofloxacin (29.8%). These antimicrobials were mostly prescribed to treat infections affecting the genitourinary tract (~30%), followed by the gastrointestinal tract, skin, and respiratory system affections. Antimicrobials in empirical associations represented 13.0% of the total antimicrobial prescriptions, and the combination of amoxicillin-clavulanic acid (Synulox) with enrofloxacin accounted for the majority. The oral route represented the main route of administration of prescribed antimicrobials, followed by parenteral and topical ones. Amoxicillin-clavulanic acid (Synulox) (37.2%), ceftriaxone (2.7%), and tobramycin (2.8%) were the most prescribed antimicrobials for the oral, parenteral, and topical routes, respectively. Antimicrobial prescriptions complied with prudent use recommendations in terms of availability of diagnosis, respect to the dose range, duration of treatment, and the use of medicinal products approved for the species. On the contrary, antimicrobial susceptibility tests were used infrequently (5.2%), lacking compliance with the existing guidelines observed in companion animal practice. Overall, additional interventions are required not only to improve the responsible use of antimicrobials in our feline practice but also to implement antimicrobial stewardship programs, enhancing diagnostics such as culture and sensitivity testing in the future.
Collapse
Affiliation(s)
| | | | - Valentina Meucci
- Veterinary Teaching Hospital, Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy; (L.D.M.); (M.V.); (A.B.); (I.L.); (V.M.); (L.I.)
| | | | | | | | | |
Collapse
|
7
|
Giannotti A, Musco S, Miragliotta V, Lazzarini G, Pirone A, Briganti A, Verardo C, Bernini F, Del Popolo G, Micera S. Swine Pudendal Nerve as a Model for Neuromodulation Studies to Restore Lower Urinary Tract Dysfunction. Int J Mol Sci 2024; 25:855. [PMID: 38255927 PMCID: PMC10815560 DOI: 10.3390/ijms25020855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Revised: 01/08/2024] [Accepted: 01/08/2024] [Indexed: 01/24/2024] Open
Abstract
Lower urinary tract dysfunction, such as incontinence or urinary retention, is one of the leading consequences of neurological diseases. This significantly impacts the quality of life for those affected, with implications extending not only to humans but also to clinical veterinary care. Having motor and sensory fibers, the pudendal nerve is an optimal candidate for neuromodulation therapies using bidirectional intraneural prostheses, paving the way towards the restoration of a more physiological urination cycle: bladder state can be detected from recorded neural signals, then an electrical current can be injected to the nerve based on the real-time need of the bladder. To develop such prostheses and investigate this novel approach, animal studies are still required since the morphology of the target nerve is fundamental to optimizing the prosthesis design. This study aims to describe the porcine pudendal nerve as a model for neuromodulation studies aiming at restoring lower urinary tract dysfunction. Five male farm pigs were involved in the study. First, a surgical procedure to access the porcine pudendal nerve without muscle resection was developed. Then, an intraneural interface was implanted to confirm the presence of fibers innervating the external urethral sphincter by measuring its electromyographic activity. Finally, the morphophysiology of the porcine pudendal nerve at the level of surgical exposure was described by using histological and immunohistochemical characterization. This analysis confirmed the fasciculate nature of the nerve and the presence of mixed fibers with a spatial and functional organization. These achievements pave the way for further pudendal neuromodulation studies by using a clinically relevant animal model with the potential for translating the findings into clinical applications.
Collapse
Affiliation(s)
- Alice Giannotti
- The BioRobotics Institute and Department of Excellence in Robotics and AI, Scuola Superiore Sant’Anna, 56127 Pisa, Italy; (A.G.); (C.V.)
| | - Stefania Musco
- Neuro-Urology Department, Careggi University Hospital, 50134 Firenze, Italy; (S.M.); (G.D.P.)
| | - Vincenzo Miragliotta
- Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy; (V.M.); (G.L.); (A.P.); (A.B.)
| | - Giulia Lazzarini
- Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy; (V.M.); (G.L.); (A.P.); (A.B.)
| | - Andrea Pirone
- Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy; (V.M.); (G.L.); (A.P.); (A.B.)
| | - Angela Briganti
- Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy; (V.M.); (G.L.); (A.P.); (A.B.)
| | - Claudio Verardo
- The BioRobotics Institute and Department of Excellence in Robotics and AI, Scuola Superiore Sant’Anna, 56127 Pisa, Italy; (A.G.); (C.V.)
| | - Fabio Bernini
- BioMedLab, Scuola Superiore Sant’Anna, 56127 Pisa, Italy;
| | - Giulio Del Popolo
- Neuro-Urology Department, Careggi University Hospital, 50134 Firenze, Italy; (S.M.); (G.D.P.)
| | - Silvestro Micera
- The BioRobotics Institute and Department of Excellence in Robotics and AI, Scuola Superiore Sant’Anna, 56127 Pisa, Italy; (A.G.); (C.V.)
- Bertarelli Foundation Chair in Translational NeuroEngineering, Center for Neuroprosthetics and Institute of Bioengineering, École Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland
| |
Collapse
|
8
|
Di Franco C, Cipollini C, Figà Talamanca G, Tazioli G, Patroncini S, Calistri M, Briganti A. Saphenous and Sciatic Nerve Blockade with and without Obturator Nerve Block for Tibial Plateau Levelling Osteotomy Surgery in Dogs: A Randomized Controlled Trial. Animals (Basel) 2023; 13:3792. [PMID: 38136829 PMCID: PMC10740557 DOI: 10.3390/ani13243792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2023] [Revised: 12/03/2023] [Accepted: 12/06/2023] [Indexed: 12/24/2023] Open
Abstract
The objective of our study was to compare the efficacy of sciatic and saphenous ultrasound nerve blocks with and without US-guided obturator nerve block in dogs undergoing tibial-plateau-levelling-osteotomy (TPLO) surgery. This study was developed in two phases: identification of an ultrasound window in the inguinal region for obturator nerve block and utilization of it in dogs undergoing TPLO. Dogs were assigned randomly to one of two groups: one received the three blocks with 0.5% ropivacaine (ON group) and the second one (NoON group) with NaCl instead of ropivacaine for the obturator block. In phase 1, the obturator nerve was visible between the pectineus and the abductor muscles and was approached using an in-plane technique. It was possible to use the ultrasound window for phase two. The number of dogs that received at least one bolus of intraoperative rescue analgesia in the NoON group (12/15 dogs) was significantly higher (p = 0.003) in comparison with the ON group (4/15). An ultrasound window to block the obturator nerve in the inguinal compartment with an in-plane technique was found. The use of this approach could produce adequate analgesia with less motor function impairment in dogs for TPLO surgery.
Collapse
Affiliation(s)
- Chiara Di Franco
- Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy; (C.D.F.); (C.C.); (S.P.)
| | - Chiara Cipollini
- Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy; (C.D.F.); (C.C.); (S.P.)
| | - Giacomo Figà Talamanca
- Clinica Veterinaria Valdinievole, Monsummano Terme, 51015 Pistoia, Italy; (G.F.T.); (G.T.); (M.C.)
| | - Giulio Tazioli
- Clinica Veterinaria Valdinievole, Monsummano Terme, 51015 Pistoia, Italy; (G.F.T.); (G.T.); (M.C.)
| | - Stefano Patroncini
- Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy; (C.D.F.); (C.C.); (S.P.)
| | - Maurizio Calistri
- Clinica Veterinaria Valdinievole, Monsummano Terme, 51015 Pistoia, Italy; (G.F.T.); (G.T.); (M.C.)
| | - Angela Briganti
- Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy; (C.D.F.); (C.C.); (S.P.)
| |
Collapse
|
9
|
Di Franco C, Evangelista F, Briganti A. Multiple uses of dexmedetomidine in small animals: a mini review. Front Vet Sci 2023; 10:1135124. [PMID: 37342619 PMCID: PMC10278766 DOI: 10.3389/fvets.2023.1135124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2022] [Accepted: 05/10/2023] [Indexed: 06/23/2023] Open
Abstract
Dexmedetomidine is an alpha-2 adrenergic agonist, which use had an exponential increase in human and veterinary medicine in the last 10 years. The aim of this mini review is to summarize the various uses of dexmedetomidine underlining its new applications and capabilities in the small animals' clinical activity. While this drug was born as sedative in veterinary medicine, some studies demonstrated to be effective as an analgesic both in single administration and in continuous infusion. Recent studies have also shown the role of dexmedetomidine as an adjuvant during locoregional anesthesia, increasing the duration of the sensitive block and consequently decreasing the demand for systemic analgesics. The various analgesic properties make dexmedetomidine an interesting drug for opioid-free analgesia. Some studies highlighted a potential neuroprotective, cardioprotective and vasculoprotective role of dexmedetomidine, thus conferring it a place in critical care medicine, such as trauma and septic patients. Dexmedetomidine has demonstrated to be a multitasking molecule and it is ready to face new challenges.
Collapse
Affiliation(s)
- Chiara Di Franco
- Department of Veterinary Sciences, University of Pisa, Pisa, Italy
| | - Flavia Evangelista
- Department of Veterinary Sciences, University of Pisa, Pisa, Italy
- Vet Hospital H24, Firenze, Italy
| | - Angela Briganti
- Department of Veterinary Sciences, University of Pisa, Pisa, Italy
| |
Collapse
|
10
|
Tappero S, Barletta F, Piccinelli M, Cano Garcia C, Incesu RB, Morra S, Chierigo F, Tian Z, Parodi S, Dell’Oglio P, Briganti A, De Cobelli O, Chun F, Graefen M, Mirone V, Saad F, Shariat S, Suardi N, Borghesi M, Terrone C, Karakiewicz P. Adenocarcinoma of the bladder: Assessment of survival benefit associated with radical cystectomy and comparison with urothelial bladder cancer. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01336-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
11
|
Stabile A, Gandaglia G, Pellegrino F, Afferi L, Zhuang J, Guo H, Gontero P, Minervini A, Ploussard G, Mazzone E, Valerio M, Cucchiara V, Fossati N, Moschini M, Mattei A, Serni S, Rahota R, Beauval J, Marquis A, Rakauskas A, Van Den Bergh R, Soeterik T, Montorsi F, Briganti A. mpMRI of the prostate in patients carrying a high clinical risk of prostate cancer diagnosis: Is this imaging test necessary for diagnostic purposes in this subset of patients? Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00146-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
12
|
Barletta F, Gandaglia G, Robesti D, Bianchi L, Zattoni F, Dal Moro F, Reitano G, Rajwa P, Hübner N, Shariat S, Kesch C, Darr C, Fendler W, Gomez-Rivas J, Moreno-Sierra J, Ibañez L, Marra G, Guo H, Zhuang J, Amparore D, Checcucci E, Porpiglia F, Picchio M, Montorsi F, Briganti A. Identifying the optimal candidates for a super-extended staging pelvic lymph-node dissection in prostate cancer patients treated in the PET-PSMA era. Results from a multi-institutional series. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00700-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
13
|
Stabile A, Gandaglia G, Pellegrino F, Mazzone E, Cucchiara V, Fossati N, Moschini M, Mattei A, Afferi L, Serni S, Minervini A, Rahota RG, Ploussard G, Valerio M, Beauval J, Marquis A, Rakauskas A, Gontero P, Guo H, Zhuang J, Van Den Bergh R, Soeterik T, Montorsi F, Briganti A. Integrating index lesion volume to better classify men with indolent prostate cancer among patients with intermediate risk disease. Results from a large, multi-institutional series. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00147-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
14
|
Chierigo F, Tappero S, Panunzio A, Sorce G, Hoeh B, Piccinelli M, Hohenhorst L, Tian Z, Parodi S, Guano G, Briganti A, Chun F, Graefen M, Antonelli A, Saad F, Shariat S, De Cobelli O, Suardi N, Borghesi M, Terrone C, Karakiewicz P. Effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01337-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
15
|
Longoni M, Scilipoti P, De Angelis M, Re C, Bertini A, Avesani G, Basile G, Nocera L, Gandaglia G, Salonia A, Montorsi F, Briganti A, Moschini M. Diagnostic performance of PET-CT compared to conventional CT for lymph node staging in bladder cancer patients undergoing radical cystectomy and bilateral pelvic lymph node dissection. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01091-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
16
|
Scuderi S, Gandaglia G, Barletta F, Bianchi L, Zattoni F, Dal Moro F, Reitano G, Rajwa P, Hübner N, Shariat S, Kesch C, Darr C, Fendler W, Gomez-Rivas J, Moreno-Sierra J, Marra G, Guo H, Zhuang J, Amparore D, Checcucci E, Porpiglia F, Schiavina R, Brunocilla E, Montorsi F, Briganti A. Improving prediction of local stage by PSMA-PET: Development of a novel integrated tool for extracapsular extension and seminal vesicle invasion combining clinical and imaging features in localized prostate cancer. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01264-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
17
|
Leni R, Robesti D, Lucianò R, Gandaglia G, Stabile A, Mazzone E, Cucchiara V, Quarta L, Zaurito P, Tenace N, De Angelis M, Pellegrino A, Zaffuto E, Dehò F, De Cobelli F, Salonia A, Montorsi F, Capitanio U, Briganti A. Oncologic outcomes of patients with incidental prostate cancer: Can we rely on multiparametric mri to exclude aggressive prostate cancer? Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00339-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
18
|
Sorce G, Gandaglia G, Stabile A, Cucchiara V, Mazzone E, Fossati N, Moschini M, Mattei A, Afferi L, Serni S, Minervini A, Rahota RG, Ploussard G, Valerio M, Beavaul J, Marquis A, Rakauskas A, Gontero P, Guo H, Zhuang J, Van Den Bergh R, Soeterik T, Montorsi F, Briganti A. Has the introduction of multiparametric magnetic resonance imaging of the prostate and targeted biopsies led to a risk of overgrading of high risk prostate cancer? Results from a contemporary, large multi-institutional series. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01271-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
19
|
Villa L, Sorce G, Fallara G, Ventimiglia E, Rosiello G, Musso G, Cei F, Re C, Lucianò R, Tenace N, Larcher A, Vitale L, Salonia A, Briganti A, Montorsi F, Bertini R, Capitanio U. Management of atypical recurrence after treatment of localized renal cell carcinoma: Retrograde intrarenal surgery as an option. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01457-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
20
|
Incesu R, Barletta F, Tappero S, Panunzio A, Piccinelli M, Cano Garcia C, Tian Z, Saad F, Shariat S, Chun F, De Cobelli O, Antonelli A, Terrone C, Briganti A, Tilki D, Graefen M, Karakiewicz P. Contemporary conditional cancer-specific survival rates in stage III non-seminoma testis cancer patients: A population-based analysis. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00803-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
21
|
Rowe I, Larcher A, Belladelli F, Lucianò R, Sant’Angelo M, Doglioni C, Colecchia M, Bernardi R, Simoni M, Necchi A, Marandino L, Pipitone G, Carrera P, Re C, Cei F, Fallara G, Scotti G, Franco I, Briganti A, Montorsi F, Capitanio U, Salonia A. Renal tumor heterogeneity analysis in Von Hippel-Lindau disease using single-cell RNA sequencing. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01078-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
22
|
Basile G, Leni R, Re C, Pellegrino F, Scilipoti P, Longoni M, Cannoletta D, Necchi A, Gandaglia G, Salonia A, Briganti A, Montorsi F, Moschini M. The black box of intraoperative adverse incident reporting during radical cystectomy: Not only post-operative complications matter. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00205-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
23
|
Trevisani F, Floris M, Furian L, Capitanio U, Trepiccione F, Larcher A, Cinque A, Rosiello G, Minnei R, Maculan M, Franchini M, Bettiga A, Pani A, Capasso G, Rigotti P, Briganti A, Salonia A, Montorsi F. Surgery or Frailty: Who is the master in eGFR decline after renal surgery in living donor and renal cancer patients? Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00901-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
24
|
Rosiello G, Re C, Cei F, Basile G, Musso G, Fallara G, Belladelli F, Cignoli D, Canibus D, Soares Pinto S, Necchi A, Marandino L, Karakiewicz P, Rowe I, Villa G, Boarin M, Disabato N, Trevisani F, Bettiga A, Briganti A, Montorsi F, Salonia A, Larcher A, Capitanio U. Frailty Index in predicting surgical outcomes after partial nephrectomy in patients with renal cell carcinoma. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00892-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
25
|
Re C, Belladelli F, Cei F, Nazario T, Basile G, Musso G, Fallara G, Rosiello G, Matloob R, Moschini M, Cignoli D, Canibus D, Karakiewicz P, Rowe I, Lucianò R, Doglioni C, Colecchia M, Bertini R, Briganti A, Montorsi F, Salonia A, Larcher A, Capitanio U. Lymphovascular invasion predicts lymph node involvement in patients with renal cell carcinoma. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00504-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
26
|
Brembilla G, Gandaglia G, Stabile A, Mazzone E, Sorce G, Pellegrino F, Robesti D, Pellegrino A, Longoni M, Scilipoti P, Quarta L, Zaurito P, Di Gaeta E, Lavalle S, Cosenza M, Montorsi F, Briganti A, Esposito A, De Cobelli F. Impact of Prostate Imaging Quality (PI-QUAL) score on the detection of clinically significant prostate cancer in men undergoing MRI-targeted biopsy. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01012-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
27
|
Ratti M, Gandaglia G, Armando S, Mazzone E, Scuderi S, Barletta F, Mottet N, Williamson P, Moss C, Beyer K, Muhammad Imran O, Maclennan S, Zong J, Cornford P, Maclennan S, Aiyegbusi O, Van Hemelrijck M, Alleva E, Derevianko A, Sisca E, N’dow J, Francesco M, Briganti A. A systematic review to evaluate Patient-Reported Outcomes Measures (PROMs) for metastatic prostate cancer according to the COSMIN methodology – A PIONEER wp2 project. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01038-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
28
|
Piccinelli M, Panunzio A, Tappero S, Barletta F, Incesu RB, Luzzago S, Mistretta F, Nardini S, Tozzi M, Cozzi G, Bottero D, Ferro M, Tian Z, Saad F, Shariat S, Graefen M, Briganti A, Chun F, Terrone C, Antonelli A, De Cobelli O, Musi G, Karakiewicz P. Cancer-specific mortality free survival rates in non-metastatic non-clear cell renal carcinoma patients at intermediate/high risk of recurrence. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00506-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
29
|
Robesti D, Tenace N, Re C, Leni R, De Angelis M, Gandaglia G, Mazzone E, Stabile A, Fossati N, Gallina A, Doglioni C, Colecchia M, Montorsi F, Briganti A, Moschini M, Lucianò R. Assessing the impact of TURBT specimens review by a dedicated uropathologist on clinical decision making process: Results from a single tertiary referral center. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01097-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
30
|
Mazzone E, Gandaglia G, Stabile A, Robesti D, Necchi A, Cirulli G, Pellegrino A, Scuderi S, Raggi D, Marandino L, Barletta F, De Angelis M, Cucchiara V, Rosiello G, Sorce G, Pellegrino F, Longoni M, Scilipoti P, Fossati N, Montorsi F, Briganti A. Tailoring the optimal use of androgen-deprivation therapy concomitant to post-operative radiotherapy among men with pN1 prostate cancer. Long-term results of a large, single Institution series. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01153-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
31
|
Mazzone E, Gandaglia G, Stabile A, Cucchiara V, Rosiello G, Sorce G, Pellegrino F, Scuderi S, Barletta F, Robesti D, Leni R, De Angelis M, Pellegrino A, Longoni M, Scilipoti P, Brembilla G, De Cobelli F, Samanes Gajate A, Picchio M, Gianolli L, Van Leeuwen F, Van Oosterom M, Montorsi F, Briganti A. Defining the optimal target-to-background count rate to identify positive lymph nodes in patients undergoing robot-assisted 99mtc-PSMA-radioguided surgery for prostate cancer: A per-region analysis of a prospective, phase II study. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00694-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
32
|
Marra G, Rajwa P, Montefusco G, Van Den Bergh R, Zattoni F, Dal Moro F, Magli A, Affentranger A, Grogg J, Hermanns T, Malkiewicz B, Kowalczyk K, Shariat S, Bianchi A, Antonelli A, Gallina S, Berchiche W, Cathelineau X, Afferi L, Fankhauser C, Mattei A, Scuderi S, Briganti A, Gontero P, Gandaglia G. Impact of pre-operative PSMA PET/CT for men with cN0M0 conventional imaging and pN+ prostate cancer: Results from a multicenter study. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00296-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
33
|
Gandaglia G, Robesti D, Bianchi L, Schiavina R, Brunocilla E, Afferi L, Mattei A, Zattoni F, Rajwa P, Shariat S, Kesch C, Sierra J, Gontero P, Marra G, Guo H, Gomez Rivas J, Zhuang J, Amparore D, Dal Moro F, Porpiglia F, Darr C, Fendler W, Picchio M, Montorsi F, Briganti A. Can we rely on available models to identify candidates for extended Pelvic Lymph Node Dissection (ePLND) in men staged with PSMA-PET? External validation of the Briganti nomograms and development of a novel tool to identify optimal candidates for ePLND. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00699-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
34
|
Barletta F, Mazzone E, Gandaglia G, Bianchi L, Schiavina R, Afferi L, Mattei A, Zanotti F, Reitano G, Rajwa P, Shariat S, Kesch C, Ibanez L, Gomez-Rivas J, Marra G, Guo H, Zhuang J, Amparore D, Cisero E, Porpiglia F, Picchio M, Checcucci E, Huebner N, Montorsi F, Briganti A. Which men with cN1 prostate cancer at PSMA PET/CT represent the ideal candidate for radical prostatectomy? Development of a novel risk stratification tool for individualized approaches based on a large, multi-institutional series. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00705-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
35
|
Pellegrino F, Stabile A, Gandaglia G, Cucchiara V, Mazzone E, Leni R, Sorce G, Scuderi S, Barletta F, Robesti D, Pellegrino A, De Angelis M, Quarta L, Zaurito P, Brembilla G, Zaffuto E, Esposito A, De Cobelli F, Montorsi F, Briganti A. Impact of radiologist expertise on PI-RADS distribution and detection of clinically significant prostate cancer: Results from a single, high volume center. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01023-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
36
|
Stabile A, Leni R, Gandaglia G, Mazzone E, Cucchiara V, Pellegrino F, Rosiello G, Nocera L, Cirulli G, Robesti D, Cannoletta D, Longoni M, Scilipoti P, De Angelis M, Pellegrino A, Larcher A, Capitanio U, Montorsi F, Briganti A. A patient tailored follow-up protocol for men with prostate cancer managed with active surveillance with the use of multiparametric magnetic resonance imaging: Identifying predictors of early and late reclassification in a large single institution cohort. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00994-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
37
|
Bandini M, Lucianò R, Giannese F, Scotti G, Oneto C, Barletta F, Cirulli G, Cucchiara V, Stabile A, Mazzone E, Sorce G, Tenace N, Scarfò F, Brembilla G, Esposito A, Morelli M, Lazarevic D, De Cobelli F, Doglioni C, Gandaglia G, Tonon G, Montorsi F, Briganti A. A novel model Integrating clinical, mp-MRI, and epigenomic features to predict lymph node invasion in prostate cancer patients undergoing radical prostatectomy and pelvic lymph node dissection. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00124-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
38
|
Baiamonte G, Rosiello G, Cei F, Tenace N, Musso G, Basile G, Re C, Fallara G, Belladelli F, Cignoli D, Colecchia M, Rowe I, De Cobelli F, Pennella R, Della Corte A, Brembilla G, Bertini R, Briganti A, Necchi A, Montorsi F, Salonia A, Larcher A, Lucianò R, Capitanio U. The current role of renal tumor biopsy in the management of small renal masses: Long-term results from a prospective, single-institutional database. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01315-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
39
|
Rosiello G, Baiamonte G, Basile G, Fallara G, Re C, Musso G, Cei F, Cignoli D, Avesani G, Disabato N, Villa G, Boarin M, Canibus D, Karakiewicz P, Dehò F, Suardi N, Briganti A, Salonia A, Montorsi F, Larcher A, Capitanio U. Lawton instrumental activities of daily living scale identifies patients at high-risk of adverse outcomes after kidney surgery for renal cancer: A prospective clinical study. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00897-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
40
|
Cano Garcia C, Flammia R, Piccinelli M, Panunzio A, Tappero S, Barletta F, Incesu RB, Law K, Tian Z, Saad F, Kapoor A, Shariat S, Tilki D, Briganti A, Terrone C, Antonelli A, De Cobelli O, Hoeh B, Kluth L, Chun F, Karakiewicz P. Differences in survival of clear cell metastatic renal cell carcinoma patients according to partial vs. radical nephrectomy. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00377-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
41
|
Scuderi S, Gandaglia G, Mazzone E, Huebner N, Brunocilla E, Dal Moro F, Sartorello A, Ibanez L, Jesús MS, Mattei A, Afferi L, Shariat S, Wolfgang F, Picchio M, Marra G, Zattoni F, Reitano G, Rajwa P, Gomez-Rivas J, Kesch C, Porpiglia F, Amparore D, Checcucci E, Montorsi F, Briganti A. The prognostic impact of preoperative psma-pet on early oncological outcomes in prostate cancer patients treated with radical prostatectomy: Results of a multi-center analysis. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00297-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
42
|
Cei F, Rosiello G, Basile G, Fallara G, Re C, Musso G, Belladelli F, Pennella R, Guazzarotti G, Brembilla G, Damascelli A, Cristel G, Della Corte A, De Cobelli F, Matloob R, Bertini R, Briganti A, Salonia A, Karakiewicz P, Mottrie A, Montorsi F, Capitanio U, Larcher A. Pre-operative risk calculator for the probability of completing surgery for kidney cancer: The key role of tumour complexity and surgical experience. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00887-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
43
|
Fallara G, Martini A, Rosiello G, Belladelli F, Musso G, Cei F, Basile G, Re C, Cignoli D, De Cobelli F, Brembilla G, Marandino L, Raggi D, Gandaglia G, Mazzone E, Moschini M, Stabile A, Briganti A, Necchi A, Montorsi F, Salonia A, Larcher A, Capitanio U. Defining the most useful intermediate endpoint for overall survival in intermediate and high-risk clear cell carcinoma. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00517-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
44
|
Robesti D, Mazzone E, Gandaglia G, Stabile A, Necchi A, Raggi D, Marandino L, Cirulli G, Scuderi S, Barletta F, De Angelis M, Balestrazzi E, Fanti S, Cucchiara V, Farolfi A, Bianchi L, Schiavina R, Montorsi F, Briganti A. The prognostic role of 68Ga-PSMA PET/CT and the impact of metastasis-directed therapy on cancer progression in men with biochemical recurrence from prostate cancer. Results from a large, single Institution series. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01159-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
45
|
Ghezzo S, Brembilla G, Russo T, Gotuzzo I, Preza E, Samanes Gajate A, Mapelli P, Bezzi C, Cucchiara V, Mongardi S, Neri I, Gandaglia G, Montorsi F, Briganti A, De Cobelli F, Gianolli L, Scifo P, Picchio M. 68Ga-PSMA PET radiomics for the prediction of post-surgical ISUP grade in primary prostate cancer patients. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01024-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
46
|
Belladelli F, Re C, Cei F, Musso G, Fallara G, Basile G, Rosiello G, Cignoli D, Canibus D, Bertini A, Bertini R, Lucianò R, Tenace N, Necchi A, Raggi D, Marandino L, Montorsi F, Salonia A, Briganti A, Guazzarotti G, Brembilla G, De Cobelli F, Capitanio U, Larcher A. Clinical benefit and cost-effectiveness of a biopsy-all strategy in patients diagnosed with renal mass: Simulation of a randomized controlled trial. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01314-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
47
|
Chierigo F, Tappero S, Panunzio A, Cano Garcia C, Barletta F, Piccinelli M, Incesu RB, Parodi S, Dell’Oglio P, Antonelli A, Graefen M, Chun F, Briganti A, De Cobelli O, Saad F, Shariat S, Suardi N, Borghesi M, Terrone C, Karakiewicz P. Sarcomatoid vs. urothelial bladder cancer: Impact of radical cystectomy on cancer control outcomes. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01338-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
48
|
Droghetti M, Bianchi L, Balestrazzi E, Ceci F, Costa F, Pissavini A, Presutti M, Scarlatti R, Farolfi A, Mei R, Castellucci P, Puliatti S, Gandaglia G, Larcher A, Mottrie A, Briganti A, Morganti A, Fanti S, Montorsi F, Schiavina R, Brunocilla E. PSMA-PET for recurrent prostate cancer and guidance of salvage treatments: Is the sooner always the better? (shoot blind or sharpshooting?). Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00312-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
49
|
Pellegrino F, Gandaglia G, Stabile A, Cucchiara V, Mazzone E, Scuderi S, Barletta F, Robesti D, Pellegrino A, Quarta L, Zaurito P, Tenace N, Brembilla G, Lucianò R, De Cobelli F, Montorsi F, Briganti A. Is there a preferential lymph node metastasis pathway in prostate cancer according to the site of the index lesion at multiparametric MRI? A topographic mapping study. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00693-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
50
|
Longoni M, Scilipoti P, De Angelis M, Re C, Bertini A, Avesani G, Gandaglia G, Colombo R, Capitanio U, Salonia A, Montorsi F, Briganti A, Moschini M. Validation of the novel risk-class for non-muscle invasive bladder cancer: Comparison of oncological outcomes between very-high risk and high risk patients. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00334-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|